BACKGROUND: Symptoms of anxiety are associated with increased risk of coronary artery disease and potentially poor prognosis among patients with existing coronary artery disease, but whether symptoms of anxiety influence atherosclerotic progression among such patients is uncertain. Accordingly, we evaluated the hypotheses that symptoms of anxiety are associated with adverse clinical outcomes and progression of atherosclerosis among individuals with previous coronary artery bypass graft (CABG) surgery and saphenous vein grafts enrolled in the Post-CABG Trial. METHODS: The Post-CABG Trial randomized patients with a history of CABG surgery to either aggressive or moderate lipid lowering and to eitherwarfarin or placebo. Patients were followed up for clinical end points and coronary angiography was conducted at enrollment and after a median follow-up of 4.3 years. Anxiety symptoms were assessed at enrollment using the state portion of the Spielberger State-Trait Anxiety Inventory (STAI) in 1317 patients. RESULTS: In models adjusting for age, sex, race, treatment assignment and years since CABG surgery, a STAI score > or =40 was positively associated with risk of death or myocardial infarction (MI) (OR 1.55, 95% CI 1.01-2.36, P = .044). This association was attenuated slightly when depressive symptoms were included in the model, but lost statistical significance (P = .11). There was a dose-response relationship between STAI score and risk of death or MI. There was no association between self-reported anxiety and atherosclerotic progression of grafts. CONCLUSIONS:Anxiety symptoms are associated with increased risk of death or MI among patients with saphenous vein grafts, but this risk does not appear to be mediated by more extensive atherosclerotic progression.
RCT Entities:
BACKGROUND: Symptoms of anxiety are associated with increased risk of coronary artery disease and potentially poor prognosis among patients with existing coronary artery disease, but whether symptoms of anxiety influence atherosclerotic progression among such patients is uncertain. Accordingly, we evaluated the hypotheses that symptoms of anxiety are associated with adverse clinical outcomes and progression of atherosclerosis among individuals with previous coronary artery bypass graft (CABG) surgery and saphenous vein grafts enrolled in the Post-CABG Trial. METHODS: The Post-CABG Trial randomized patients with a history of CABG surgery to either aggressive or moderate lipid lowering and to either warfarin or placebo. Patients were followed up for clinical end points and coronary angiography was conducted at enrollment and after a median follow-up of 4.3 years. Anxiety symptoms were assessed at enrollment using the state portion of the Spielberger State-Trait Anxiety Inventory (STAI) in 1317 patients. RESULTS: In models adjusting for age, sex, race, treatment assignment and years since CABG surgery, a STAI score > or =40 was positively associated with risk of death or myocardial infarction (MI) (OR 1.55, 95% CI 1.01-2.36, P = .044). This association was attenuated slightly when depressive symptoms were included in the model, but lost statistical significance (P = .11). There was a dose-response relationship between STAI score and risk of death or MI. There was no association between self-reported anxiety and atherosclerotic progression of grafts. CONCLUSIONS:Anxiety symptoms are associated with increased risk of death or MI among patients with saphenous vein grafts, but this risk does not appear to be mediated by more extensive atherosclerotic progression.
Authors: J H Reiber; P M van der Zwet; G Koning; C D von Land; B van Meurs; J J Gerbrands; B Buis; A E van Voorthuisen Journal: Cathet Cardiovasc Diagn Date: 1993-03
Authors: William Whang; Christine M Albert; Samuel F Sears; Rachel Lampert; Jamie B Conti; Paul J Wang; Jagmeet P Singh; Jeremy N Ruskin; James E Muller; Murray A Mittleman Journal: J Am Coll Cardiol Date: 2005-04-05 Impact factor: 24.094
Authors: Christopher M Celano; Rachel A Millstein; C Andres Bedoya; Brian C Healy; Annelieke M Roest; Jeff C Huffman Journal: Am Heart J Date: 2015-09-21 Impact factor: 4.749
Authors: Zsuzsanna Cserép; Eszter Losoncz; Piroska Balog; Tamás Szili-Török; András Husz; Boglárka Juhász; Miklós D Kertai; János Gál; Andrea Székely Journal: J Cardiothorac Surg Date: 2012-09-14 Impact factor: 1.637
Authors: Zsuzsanna Cserép; Eszter Losoncz; Roland Tóth; Attila Tóth; Boglárka Juhász; Piroska Balog; Péter Vargha; János Gál; Richard J Contrada; Paul R J Falger; Andrea Székely Journal: BMC Cardiovasc Disord Date: 2014-11-29 Impact factor: 2.298
Authors: Adomas Bunevicius; Margarita Staniute; Julija Brozaitiene; Victor J M Pop; Julius Neverauskas; Robertas Bunevicius Journal: Health Qual Life Outcomes Date: 2013-03-11 Impact factor: 3.186
Authors: Manuela Aspalter; Florian K Enzmann; Thomas J Hölzenbein; Wolfgang Hitzl; Florian Primavesi; Lucia Algayerova; Patrick Nierlich; Christoph Kartnig; Reinald Seitelberger; Klaus Linni Journal: Perioper Med (Lond) Date: 2021-12-08